The Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) has announced a five-year, $20 million gift from Royalty Pharma and certain members of its management team in support of its Institute for Health Equity Research (IHER).

The gift will establish the Mount Sinai-Royalty Pharma Alliance for Health Equity Research to bolster IHER in its ongoing efforts to address healthcare disparities and translate discoveries into sustainable, scalable initiatives and policies that break down systemic barriers to care among communities in New York City, nationally, and globally. To that end, the Mount Sinai-Royalty Pharma Alliance will create opportunities for joint research collaborations that expand and leverage data of Mount Sinai’s population—one of the largest and most diverse nationwide—and Royalty Pharma’s existing data and knowledge resources to generate meaningful insights. In addition, it will provide volunteer opportunities for Royalty Pharma employees to share their expertise and skills to address IHER’s needs and advance its mission. 

“The pandemic has magnified the considerable consequences that health issues and crises create among underserved populations but also created an urgency to address these challenges,” said Dennis S. Charney, the Anne and Joel Ehrenkranz Dean of Icahn Mount Sinai and president for academic affairs of the Mount Sinai Health System. “This gift significantly enhances Mount Sinai’s ability to understand the factors that contribute to health disparities in the communities that we serve and to develop strategic, resilient solutions that remove barriers to access. We are grateful to Royalty Pharma for this generous gift as well as their partnership as we advance medicine for all patients, families, and communities.” 

(Photo credit: Getty Images/FatCamera)